Explained risk from apoB-containing lipoproteins to MI
Should there be more attention for VLDL-cholesterol with regard to MI risk in patients with high CV risk?
- Yes
- No
Educational information
This video was recorded in response to a recent publication in J Am Coll Cardiol. by prof. Børge Nordestgaard and colleagues.
Faculty
Prof. Børge Nordestgaard, MD - Professor, University of Copenhagen, Denmark/ Chief Physician, Dept. Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital Denmark.
Disclosures
This recording was developed under auspices of PACE-cme. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-cme.
The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.
Share this page with your colleagues and friends: